<DOC>
	<DOCNO>NCT02501980</DOCNO>
	<brief_summary>All participant select community test HBsAg use serum sample . Among positive HBsAg , clinical work-ups include AFP test ultrasonography liver exam perform . High risk group select accord definition . HCC diagnosis determine accord image and/or biopsy result . Repeated check-ups perform 6-months among HBsAg positive group 3-years among HBsAg negative group . All subject control arm ( control community ) follow record linkage Cancer Register Population Register .</brief_summary>
	<brief_title>Hepatocellular Cancer ( HCC ) Screening Zhongshan City</brief_title>
	<detailed_description>Sample selection - Select community 70,000 120,000 population Zhongshan City investigator ' field . - Divide screen group control group accord area administration Participants recruitment - Subjects voluntarily attend screen study Informed consent - Informed consent form collect recruitment . Questionnaires - Face-to-face interview conduct well-trained investigator Serological test - Each blood sample test surface antigen hepatitis B virus ( HBsAg ) . - Among positive HBsAg , clinical work-ups include Alpha-Fetoprotein ( AFP ) test ultrasonography liver exam perform high risk group select accord definition . - HCC diagnosis determine accord image and/or biopsy result . - The rest blood sample store biobank Zhongshan People 's Hospital . Follow - The cohort follow accord screen protocol . Briefly , Repeated check-ups perform 6-months among HBsAg positive group 3-years among HBsAg negative group . - All subject control arm ( control community ) follow record linkage Cancer Register Population Register .</detailed_description>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>Residences Zhongshan City Have medical record hepatocellular cancer ECOG 02 Provide write informed consent form Have good physical psychological condition Have severe cardiovascular kidney disease Have medical record hepatocellular cancer</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Screening</keyword>
	<keyword>Hepatocellular Cancer</keyword>
	<keyword>Biomarker</keyword>
	<keyword>Mortality rate</keyword>
</DOC>